Sign in
Download Opera News App

HOMEPAGE

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis · Wall Street Call

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis · Wall Street Call

With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development, the demand for R&D and manufacturing services for such products is anticipated to increase beyond the capabilities of innovator companies alone London Roots Analysis has announced the addition of “Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active...

Read Full Story
London Roots Analysis Wall Street

Top News

US POLITICS

De Blasio: If Cuomo accusations are true, 'he can't govern'

foxnews.com
De Blasio: If Cuomo accusations are true, 'he can't govern'

US POLITICS

De Blasio: If Cuomo accusations are true, 'he can't govern'

foxnews.com

US POLITICS

Allegations against Cuomo become headache for Democrats from Albany to Washington

politico.com
Allegations against Cuomo become headache for Democrats from Albany to Washington

US POLITICS

Allegations against Cuomo become headache for Democrats from Albany to Washington

politico.com